| 000 | 01723 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515030357.0 | ||
| 264 | 0 | _c20060911 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/j.ejca.2006.02.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrosso, F | |
| 245 | 0 | 0 |
_aSteroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cJul 2006 |
||
| 300 |
_a1484-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadverse effects |
| 650 | 0 | 4 |
_aBone Marrow Diseases _xchemically induced |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 |
_aDioxoles _xadverse effects |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Diseases _xprevention & control |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPremedication |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aSteroids _xtherapeutic use |
| 650 | 0 | 4 |
_aTetrahydroisoquinolines _xadverse effects |
| 650 | 0 | 4 | _aTrabectedin |
| 700 | 1 | _aDileo, P | |
| 700 | 1 | _aSanfilippo, R | |
| 700 | 1 | _aStacchiotti, S | |
| 700 | 1 | _aBertulli, R | |
| 700 | 1 | _aPiovesan, C | |
| 700 | 1 | _aJimeno, J | |
| 700 | 1 | _aD'Incalci, M | |
| 700 | 1 | _aGescher, A | |
| 700 | 1 | _aCasali, P G | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 42 _gno. 10 _gp. 1484-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2006.02.010 _zAvailable from publisher's website |
| 999 |
_c16334705 _d16334705 |
||